| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0069 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |